Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 10-Q stay in one workspace.
IMVT
$34.18
-2.48%
IMVT
· Immunovant, Inc.
$34.18
-0.87 (-2.48%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$7.07B
Shares
206.95M
Volume · Nov 13
864.88K
Avg daily vol (3M)
1.43M
All webcasts
Earnings call · FY2027 Q1
Immunovant, Inc. (IMVT) Q1 2027 Earnings Call
Diluted EPS
-$0.75
Net income
-$153.22M
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Company presentation
Slides
69 pages · use arrow keys or swipe to navigate
SEC filing · Item 2.02
8-K earnings release
Filed Aug 6, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 6, 2026 · complete as-filed document